Our discovery that the CAII-based tumor cell phenotype is closely associated with ferroptosis susceptibility is significant, because it suggests that the metabolic trait of ES malignancies might offer a possibility for new therapeutic interventions. This evidence concerns the gene CA2 and neoplasm.